Home/Filings/4/0001562180-23-001539
4//SEC Filing

Mango Lisa A 4

Accession 0001562180-23-001539

CIK 0001404123other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 8:46 PM ET

Size

19.4 KB

Accession

0001562180-23-001539

Insider Transaction Report

Form 4
Period: 2023-02-15
Mango Lisa A
General Counsel and Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-15+11,52599,910 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-1511,52534,573 total
    Common Stock (11,525 underlying)
  • Exercise/Conversion

    Common Stock

    2023-02-15+2,221102,131 total
  • Sale

    Common Stock

    2023-02-16$15.36/sh7,596$116,64494,535 total
  • Sale

    Common Stock

    2023-02-17$15.32/sh6,150$94,21688,385 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-152,2214,441 total
    Common Stock (2,221 underlying)
Footnotes (6)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units ("RSUs") convert into the issuer's common stock on a one-for-one basis.
  • [F2]Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the reporting person.
  • [F3]This transaction was executed in multiple trades at prices ranging from $15.31 to $15.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
  • [F5]This transaction was executed in multiple trades at prices ranging from $15.30 to $15.355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]The RSUs vest in equal annual installments over four years on the anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.

Issuer

1Life Healthcare Inc

CIK 0001404123

Entity typeother

Related Parties

1
  • filerCIK 0001800511

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 8:46 PM ET
Size
19.4 KB